New personalized cancer vaccine cuts Melanoma recurrence risk by 42%, trial showsA world-first personalized cancer vaccine has been shown to cut the risk of melanoma returning or resulting in death by 42% when administered alongside standard immunotherapy. The vaccine, called Intismeran, uses the. ..
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan